Diabetes Drugs and Pancreatic Cancer: Incretin Mimetic Class Drugs May Cause An Increased Risk of Pancreatic Cancer by Diabetes Drug Cancer Lawyer Jason S. Coomer

Diabetes Drugs and Pancreatic Cancer: Incretin Mimetic Class Drugs May Cause An Increased Risk of Pancreatic Cancer by Diabetes Drug Cancer Lawyer Jason S. Coomer

 

Recent scientific studies have shown that some diabetes drugs in the incretin mimetic class may cause an increased health risk of pancreatic cancer and pancreatitis.  These incretin diabetes drugs include exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto). These drugs work by mimicking the incretin hormones that the body usually produces naturally to stimulate the release of insulin in response to a meal. They are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.  Many of these incretin diabetes drugs already include a black box warning regarding thyroid cancer risk, but evidence is growing that these drugs may also create an increased risk of pancreatic cancer.

 

If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one who was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.   For more information on diabetes drug pancreatic cancer lawsuits, please feel free to send an e-mail message to Pancreatic Cancer Lawyer Jason Coomer or go to the following pages: Januvia, Janument, Victoza, Byetta, Onglyza, Bydureon, and diabetes drugs.  

 

 Diabetics Should Be Aware of Incretin Drug Pancreatic Cancer Health Risk

 

Diabetics who are taking incretin diabetes drugs including: Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta,  Oseni, and other diabetes drugs should be aware of the cancer health risks and discuss these potential health risks with their physicians.

• For more information on Januvia and Janumet Pancreatic Cancer, please go to the following web page on Januvia Pancreatic Cancer Lawsuits and Janumet Pancreatic Cancer Lawsuits.
• For more information on Byetta Pancreatic Cancer, please go to the following web page on Byetta Pancreatic Cancer Lawsuits and Exenatide Pancreatic Cancer Lawsuits.
• For more information on Victoza Pancreatic Cancer, please go to the following web page on Victoza Pancreatic Cancer Lawsuits and Victoza Cancer Death Lawsuits.